Skip to main content
. 2021 Feb 2;11:2800. doi: 10.1038/s41598-021-82634-1

Figure 1.

Figure 1

The cellular biology of cancer cells in circulation is poorly understood, hindering the development of efficient therapies. The majority of current treatments are aimed at treating the primary tumor or their metastatic deposits. There is little known about the treatment of cells in circulation, which are also called circulating tumor cells (CTCs). It remains unclear how some cells within the primary tumor can survive prolonged circulation to develop metastatic disease.